Asia Pacific Insulin Market By Product (Rapid Acting, Short Acting, Pre-Mixed, Long Acting) ,By Application (Type I & II Diabetes ),By Source( Analogs & Recombinant Insulin) And Segment Forecasts To 2020Report

Asia Pacific Insulin Market By Product (Rapid Acting, Short Acting, Pre-Mixed, Long Acting) ,By Application (Type I & II Diabetes ),By Source( Analogs & Recombinant Insulin) And Segment Forecasts To 2020

  • Report ID: 978-1-68038-135-1
  • Number of Pages: 95
  • Format: Electronic (PDF)

Table of Contents

Chapter 1. Executive Summary
                  1.1. Asia Pacific Insulin - Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Asia Pacific Insulin Industry Outlook
                  2.1. Market Segmentation
                  2.2. Market Size and Growth Prospects
                  2.3. Asia Pacific Insulin Market Dynamics
                       2.3.1. Market Driver Analysis
                       2.3.2. Market Restraint Analysis
                  2.4. Key Opportunities Prioritized
                  2.5. Industry Analysis - Porter's
                  2.6. Asia Pacific Insulin - Company Market Share Analysis
                  2.7. Asia Pacific Insulin Market PESTEL Analysis, 2012
                  2.8. Asia Pacific Insulin - Pipeline Overview
Chapter 3. Asia Pacific Insulin Product Outlook, Volume (number of units) and Value (USD Million) Estimates and Forecasts, 2012 - 2020
                  3.1. Rapid Acting Analog
                       3.1.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020
                  3.2. Short Acting Insulin
                       3.2.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020
                  3.3. Intermediate Acting Insulin
                       3.3.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020
                  3.4. Long Acting Analog
                       3.4.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020
                  3.5. Pre-Mixed
                       3.5.1. Pre-Mixed Insulin Market Estimates and Forecasts
                            3.5.1.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020
                       3.5.2. Pre-Mixed Analog Market Estimates and Forecasts
                            3.5.2.1. Pricing Analysis (Average Selling Price in USD), 2012 - 2020
Chapter 4. Asia Pacific Insulin Segment (on the basis of source) Outlook, Volume (number of units) and Value (USD Million) Estimates and Forecasts, 2012 - 2020
                  4.1. Insulin Analogs
                       4.1.1.Insulin Analogs Market Estimates and Forecasts
                  4.2. Human Recombinant Insulin
                       4.2.1. Human Recombinant Insulin Market Estimates and Forecasts
Chapter 5. Asia Pacific Insulin Application Outlook (USD Million) Estimates and Forecasts, 2012 - 2020
                  5.1. Type I and Other Diabetes
                       5.1.1. Type I and Other Diabetes Market Estimates and Forecasts
                  5.2. Type II Diabetes
                       5.2.1. II Diabetes Market Estimates and Forecasts
Chapter 6. Insulin Regional Outlook, Volume (number of units) and Value (USD Million) Estimates and Forecasts, 2012 - 2020
                  6.1. India
                       6.1.1. India Insulin Market, by Products
                       6.1.2. India Insulin Market, by Applications (only revenue)
                       6.1.3. India Insulin Market, by Source
                  6.2. China
                       6.2.1. China Insulin Market, by Products
                       6.2.2. China Insulin Market, by Applications (only revenue)
                       6.2.3. China Insulin Market, by Source
                  6.3. Australia
                       6.3.1. Australia Insulin Market, by Products
                       6.3.2. Australia Insulin Market, by Applications (only revenue)
                       6.3.3. Australia Insulin Market, by Source
                  6.4. New Zealand
                       6.4.1. New Zealand Insulin Market, by Products
                       6.4.2. New Zealand Insulin Market, by Applications (only revenue)
                       6.4.3. New Zealand Insulin Market, by Source
                  6.5. South Korea
                       6.5.1. South Korea Insulin Market, by Products
                       6.5.2. South Korea Insulin Market, by Applications (only revenue)
                       6.5.3. South Korea Insulin Market, by Source
                  6.6. Taiwan
                       6.6.1. Taiwan Insulin Market, by Products
                       6.6.2. Taiwan Insulin Market, by Applications (only revenue)
                       6.6.3. Taiwan Insulin Market, by Source
                  6.7. Philippines
                       6.7.1. Philippines Insulin Market, by Products
                       6.7.2. Philippines Insulin Market, by Applications (only revenue)
                       6.7.3. Philippines Insulin Market, by Source
                  6.8. Vietnam
                       6.8.1. Vietnam Insulin Market, by Products
                       6.8.2. Vietnam Insulin Market, by Applications (only revenue)
                       6.8.3. Vietnam Insulin Market, by Source
                  6.9. Indonesia
                       6.9.1. Indonesia Insulin Market, by Products
                       6.9.2. Indonesia Insulin Market, by Applications (only revenue)
                       6.9.3. Indonesia Insulin Market, by Source
                  6.10. Japan
                       6.10.1. Japan Insulin Market, by Products
                       6.10.2. Japan Insulin Market, by Applications (only revenue)
                       6.10.3. Japan Insulin Market, by Source
                  6.11. Malaysia
                       6.11.1. Malaysia Insulin Market, by Products
                       6.11.2. Malaysia Insulin Market, by Applications (only revenue)
                       6.11.3. Malaysia Insulin Market, by Source
                  6.12. Thailand
                       6.12.1. Thailand Insulin Market, by Products
                       6.12.2. Thailand Insulin Market, by Applications (only revenue)
                       6.12.3. Thailand Insulin Market, by Source
                  6.13. Rest of Asia Pacific
Companies analyzed in competitive landscape
                  1. Novo Nordisk
                  2. Sanofi
                  3. Eli Lilly
                  4. Bristol-Myers Squibb
                  5. Novartis
                  6. Takeda Pharmaceuticals
                  7. Boehringer Ingelheim
                  8. Biocon
                  9. Dongbao Enterprise Group Co., Ltd.
                  10. Merck KGaA
                  11. Oramed Pharmaceuticals Inc.
                  12. Halozyme Therapeutics
                  13. Wanbang Biopharma
                  14. Xinbai Pharmaceutical
                  15. Gan & Lee Pharmaceutical


List of Tables

1. Asia Pacific Insulin - Industry summary & Critical Success Factors (CSFs)
2. Asia Pacific Insulin Market, by Countries, 2012 - 2020 (USD Million)
3. Asia Pacific Insulin Market, by Products, 2012 - 2020 (USD Million)
4. Asia Pacific Insulin Market, by Products, 2012 - 2020 (‘000 Units)
5. Asia Pacific Insulin Market, by Applications, 2012 - 2020 (USD Million)
6. Asia Pacific Insulin Market, by Source Types, 2012 - 2020 (USD Million)
7. Asia Pacific Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
8. India Insulin Market, by Products, 2012 - 2020 (USD Million)
9. India Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
10. India Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
11. India Insulin Market, by Product Types, 2012 - 2020 ('000 units)
12. India Insulin Market, by Source Types, 2012 - 2020 (USD million)
13. India Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
14. India Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
15. China Insulin Market, by Products, 2012 - 2020 (USD Million)
16. China Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
17. China Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
18. China Insulin Market, by Product Types, 2012 - 2020 ('000 units)
19. China Insulin Market, by Source Types, 2012 - 2020 (USD million)
20. China Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
21. China Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
22. Japan Insulin Market, by Products, 2012 - 2020 (USD Million)
23. Japan Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
24. Japan Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
25. Japan Insulin Market, by Product Types, 2012 - 2020 ('000 units)
26. Japan Insulin Market, by Source Types, 2012 - 2020 (USD million)
27. Japan Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
28. Japan Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
29. South Korea Insulin Market, by Products, 2012 - 2020 (USD Million)
30. South Korea Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
31. South Korea Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
32. South Korea Insulin Market, by Product Types, 2012 - 2020 ('000 units)
33. South Korea Insulin Market, by Source Types, 2012 - 2020 (USD million)
34. South Korea Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
35. South Korea Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
36. Thailand Insulin Market, by Products, 2012 - 2020 (USD Million)
37. Thailand Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
38. Thailand Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
39. Thailand Insulin Market, by Product Types, 2012 - 2020 ('000 units)
40. Thailand Insulin Market, by Source Types, 2012 - 2020 (USD million)
41. Thailand Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
42. Thailand Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
43. Malaysia Insulin Market, by Products, 2012 - 2020 (USD Million)
44. Malaysia Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
45. Malaysia Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
46. Malaysia Insulin Market, by Product Types, 2012 - 2020 ('000 units)
47. Malaysia Insulin Market, by Source Types, 2012 - 2020 (USD million)
48. Malaysia Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
49. Malaysia Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
50. Vietnam Insulin Market, by Products, 2012 - 2020 (USD Million)
51. Vietnam Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
52. Vietnam Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
53. Vietnam Insulin Market, by Product Types, 2012 - 2020 ('000 units)
54. Vietnam Insulin Market, by Source Types, 2012 - 2020 (USD million)
55. Vietnam Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
56. Vietnam Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
57. Australia Insulin Market, by Products, 2012 - 2020 (USD Million)
58. Australia Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
59. Australia Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
60. Australia Insulin Market, by Product Types, 2012 - 2020 ('000 units)
61. Australia Insulin Market, by Source Types, 2012 - 2020 (USD million)
62. Australia Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
63. Australia Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
64. New Zealand Insulin Market, by Products, 2012 - 2020 (USD Million)
65. New Zealand Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
66. New Zealand Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
67. New Zealand Insulin Market, by Product Types, 2012 - 2020 ('000 units)
68. New Zealand Insulin Market, by Source Types, 2012 - 2020 (USD million)
69. New Zealand Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
70. New Zealand Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
71. Indonesia Insulin Market, by Products, 2012 - 2020 (USD Million)
72. Indonesia Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
73. Indonesia Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
74. Indonesia Insulin Market, by Product Types, 2012 - 2020 ('000 units)
75. Indonesia Insulin Market, by Source Types, 2012 - 2020 (USD million)
76. Indonesia Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
77. Indonesia Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
78. Philippines Insulin Market, by Products, 2012 - 2020 (USD Million)
79. Philippines Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
80. Philippines Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
81. Philippines Insulin Market, by Product Types, 2012 - 2020 ('000 units)
82. Philippines Insulin Market, by Source Types, 2012 - 2020 (USD million)
83. Philippines Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
84. Philippines Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
85. Taiwan Insulin Market, by Products, 2012 - 2020 (USD Million)
86. Taiwan Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
87. Taiwan Insulin Prices in Private Sector, by Product Types, 2012 - 2020 (USD/Unit)
88. Taiwan Insulin Market, by Product Types, 2012 - 2020 ('000 units)
89. Taiwan Insulin Market, by Source Types, 2012 - 2020 (USD million)
90. Taiwan Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
91. Taiwan Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)


List of Figures

1. Asia Pacific Insulin Market Segmentation
2. Asia Pacific Insulin Market Revenue, 2012 - 2020
3. Asia Pacific Insulin Market Dynamics
4. Asia Pacific Insulin Company Market Share Analysis, 2012
5. Key Opportunities Prioritized
6. Industry Analysis - Porter's
7. Asia Pacific Insulin PESTEL Analysis, 2012
8. Asia Pacific Insulin market - company market share analysis, 2013 (%)
9. Asia Pacific insulin market, by product type, 2012 - 2020
10. Asia Pacific insulin market, by source types, 2012 - 2020
11. Asia Pacific insulin market, by applications, 2012 - 2020

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon